The Sanford Research Center for Genomic and Molecular Medicine will develop and test specific genetic markers for medication metabolism and susceptibility to common chronic diseases, such as cancer and heart disease. Through a simple blood draw, your DNA will be clinically analyzed in house by our team of experts.
This unique genomic diagnostic tool will initially be used to uncover how patients metabolize more than 35 different medications and classes of medications. This allows our physicians the ability to be proactive with their treatments and prescribe the right medication at the right dose for each patient.
Such precision in care means fewer adverse drug reactions and a higher overall quality of care for you. Later, tests will be developed to predict adults susceptibility to common chronic diseases.
This technology will allow Sanford Health to take a national lead role in using existing genetic markers and discovering new genetic markers to individualize care for patients with cancer, diabetes, hypertension, coronary artery disease and other conditions.